Galvamark Met 50mg/500mg

Galvamark Met 50mg/500mg is a combination of Metformin (500 mg) and Vildagliptin (50 mg) formulated for the effective management of type 2 diabetes. Metformin enhances insulin sensitivity and reduces hepatic glucose production while Vildagliptin a DPP-4 inhibitor increases incretin levels promoting insulin secretion in response to meals and lowering glucagon levels. This synergistic formulation helps maintain stable blood sugar levels improves glycemic control and reduces the risk of diabetes-related complications.